Tue, Dec 23, 2014, 12:31 AM EST - U.S. Markets open in 8 hrs 59 mins


% | $
Quotes you view appear here for quick access.

RXi Pharmaceuticals Corporation Message Board

  • peaksisland@rocketmail.com peaksisland Mar 29, 2013 5:08 PM Flag

    10-K was just filed!

    Look's like RXI didn't lie to the SEC:

    --- "We expect to incur significant operating losses as we advance our product candidates through the drug development and regulatory process. We have generated significant losses to date, have not generated any product revenue to date and may not generate product revenue in the foreseeable future, if ever. In the future, RXi will be dependent on obtaining funding from third parties, such as proceeds from the issuance of debt, sale of equity, funded research and development programs and payments under partnership and collaborative agreements, in order to maintain RXi’s operations and meet RXi’s obligations to licensors. There is no guarantee that debt, additional equity or other funding will be available to the Company on acceptable terms, or at all. If the Company fails to obtain additional funding when needed, RXi would be forced to scale back, or terminate the Company operations or to seek to merge with or to be acquired by another company." ---

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.600.00(0.00%)Dec 22 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
ImmunoGen, Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST